✦ LIBER ✦

JAK-2V617F mutation in RARS-t: A target for Imatinib therapy?

✍ Scribed by Elisa Cannizzo; Giovanni Carulli; Antonio Azzarà; Sara Galimberti; Alessandra Zucca; Mario Petrini

Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 94 KB
Volume: 32
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disappearance of JAK2 V617F mutation in

Disappearance of JAK2 V617F mutation in a rapid leukemic transformed essential thrombocythemia patient

✍ Hui-Hua Hsiao; Wen-Chi Yang; Yi-Chang Liu; Ching-Ping Lee; Sheng-Fung Lin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Isolated erythrocytosis in V617F negativ

Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation

✍ Martina Bernardi; Marco Ruggeri; Elena Albiero; Domenico Madeo; Francesco Rodegh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

Is JAK2 V617F mutation more than a diagn

Is JAK2 V617F mutation more than a diagnostic index?: A meta-analysis of clinical outcomes in essential thrombocythemia

✍ Issa J. Dahabreh; Katerina Zoi; Stavroula Giannouli; Christine Zoi; Dimitrios Lo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Cyclic severe elevated procalcitonin ser

Cyclic severe elevated procalcitonin serum levels in a patient with post polycythemic myelofibrosis carrying a V617F-JAK2 mutation

✍ F. Stölzel; J. Babatz; C. Thiede; G. Siegert; T. Illmer; G. Ehninger; M. Schaich 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 91 KB

Clinical JAK2V617F mutation testing: Lim

Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations

✍ Gregory A. Abel; Daniel J. DeAngelo; Jean M. Connors; Lynette M. Sholl; Ronald P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

JAK2 (V617F) as an acquired somatic muta

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders

✍ Elisa Rumi; Francesco Passamonti; Daniela Pietra; Matteo G. Della Porta; Luca Ar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views